Previous studies have shown that the Dnmt3b gene encodes multiple variants via alternative splicing. However, only one form of Dnmt3a has been identified to date. We report here the discovery of a small form of Dnmt3a, denoted Dnmt3a2, from both human and mouse. The transcript encoding Dnmt3a2 is initiated from a downstream intronic promoter. As a result, the Dnmt3a2 protein lacks the N-terminal 223 (human) or 219 (mouse) amino acid residues of the full-length Dnmt3a. Recombinant Dnmt3a2 protein displayed similar cytosine methyltransferase activity as Dnmt3a in vitro. However, Dnmt3a and Dnmt3a2 exhibited strikingly different subcellular localization patterns. Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association. Dnmt3a2 is the predominant form in embryonic stem cells and embryonal carcinoma cells and can also be detected from testis, ovary, thymus, and spleen, whereas Dnmt3a is expressed at low levels ubiquitously. Comparison of human embryonal carcinoma cell lines with breast/ovarian cancer cell lines indicates that DNMT3A2 expression correlates with high de novo methylation activity. These findings suggest that Dnmt3a and Dnmt3a2 may have distinct DNA targets and different functions in development.
Four DNA cytosine-5 methyltransferases (Dnmts), 1 namely Dnmt1, Dnmt2, Dnmt3a, and Dnmt3b, have been identified in humans and mice (1) (2) (3) (4) (5) . Inactivation of either Dnmt1 or Dnmt3a and Dnmt3b in mice by gene targeting leads to hypomethylation of the genome and embryonic lethality, indicating that DNA methylation is essential for mammalian development (6, 7) . Although both Dnmt1 and the Dnmt3 family of enzymes methylate predominantly CpG dinucleotides in vitro, genetic studies reveal that these two classes of enzymes display different activities and functions in vivo. Dnmt1 is primarily responsible for the maintenance of DNA methylation patterns in proliferating cells, whereas Dnmt3a and Dnmt3b are necessary for de novo methylation and for the establishment of new methylation patterns in mammalian cells and transgenic flies (7) (8) (9) (10) .
In mice, DNA methylation patterns are established during embryonic development through dynamic regulation of de novo methylation and demethylation. De novo methylation also occurs during gametogenesis in both male and female germ cells and is believed to play a critical role in the establishment of genomic imprinting in the gametes. Genomic imprinting is an epigenetic process that marks alleles according to their parental origin during gametogenesis and results in monoallelic expression of a small set of genes (known as imprinted genes) in the offspring (for reviews, see Refs. 11 and 12) . Recent studies have shown that Dnmt3a is required for the establishment of methylation imprints in the oocytes (13) . De novo methylation has been detected mainly in embryonic stem (ES) cells and embryonal carcinoma (EC) cells, early embryos, and developing germ cells, whereas it is largely suppressed in differentiated somatic cells (8, 14 -16) . Because aberrant de novo methylation of CpG sites in promoter sequences can lead to abnormal gene silencing and is associated with diseases such as cancers (17) , it is believed that de novo methylation must be under tight regulation during development. Dnmt1 is expressed ubiquitously, and its function is required for the survival of somatic cells (8, 18) . Dnmt3a and Dnmt3b, on the other hand, are regulated during development (4, 7) . Although both Dnmt3a and Dnmt3b transcripts are present at very low levels in somatic cells, they are expressed at high levels in ES cells and germ cells in which active de novo methylation is detected.
Several different Dnmt3b transcripts, resulting from alternative splicing of exons 10, 21, and/or 22, have been reported (4, 5, 19, 20) . Dnmt3b1 and Dnmt3b2 are enzymatically active in standard DNA methyltransferase assays, whereas Dnmt3b3, which lacks part of motif IX, appears to be inactive (4, 21) . Dnmt3b4 and Dnmt3b5 encode truncated proteins that lack motifs IX and X and are presumably inactive (19, 20) . So far, only one form of Dnmt3a has been identified and shown to be capable of methylating DNA both in vitro and in vivo (4, 7, 9, 10, 21) . DNA methylation may also be regulated through subcellular localization of Dnmt3a and Dnmt3b. Tagged Dnmt3a and Dnmt3b proteins have been shown to localize preferentially to the heterochromatin in transfected cells (22) . Dnmt3a and Dnmt3b have been shown to interact with histone deacetylases (HDAC1 and HDAC2) and transcription factors RP58 and PML (22) (23) (24) , which may target Dnmt3a and Dnmt3b to transcriptionally silent heterochromatin. Although the majority of CpG islands, which usually localize in euchromatin regions, are methylation-free, some CpG islands become methylated during development or under pathological conditions such as in cancer cells (25) . It remains unknown how DNA methylation is differentially regulated in different chromatin regions and what enzymes are involved.
In this study, we report the identification of a novel isoform of Dnmt3a, termed Dnmt3a2, which is encoded by transcripts initiated from an intronic promoter. Dnmt3a2 has similar methyltransferase activity to Dnmt3a, but it localizes to euchromatin instead of heterochromatin. Moreover, Dnmt3a2 expression is tightly regulated and correlates with high de novo methylation activity, whereas Dnmt3a is expressed ubiquitously. Therefore, Dnmt3a and Dnmt3a2 may methylate distinct DNA targets and have different functions in development.
EXPERIMENTAL PROCEDURES
Vectors-The GFP-Dnmt3a and GFP-Dnmt3b, the Dnmt3a-and Dnmt3b-pcDNA, and the His 6 -tagged Dnmt3a constructs were generated by subcloning the corresponding Dnmt3a or Dnmt3b cDNA into pEGFP-C1 (CLONTECH), pcDNA6/V5-HisA (Invitrogen), and pET28b(ϩ) (Novagen), respectively. The luciferase reporter constructs were generated by inserting a ϳ2.0-kb Dnmt3a genomic fragment, which contains a putative promoter (P2), in forward (P2-luc) or reverse (P2R-luc) orientation into pGL3-Basic (Promega). The P2 targeting vector was constructed by sequentially subcloning Dnmt3a genomic fragments (arms), the hCMV-hygTK cassette, and the PGK-DTA cassette into pBluescript II SK. All of the Dnmt3a genomic fragments were generated by PCR using a BAC clone (Genome Systems Inc.) as the template and the following pairs of oligonucleotides as primers: 5Ј-CTGGGATC-CAGGCACCTGGGGTGTTACCT-3Ј and 5Ј-GGTGGATCCCCTCTGCA-GTACAGCTC-3Ј (for P2-luc and P2R-luc), 5Ј-CTGGAATTCTCCTAC-CTT TG-3Ј and 5Ј-CCTGGATCCCAGCCAGTGAGCTGG-3Ј (for P2 targeting vector, 5Ј arm, 3.7 kb), and 5Ј-GTTCCGCGGCTGCTCATT-3Ј and 5Ј-CCACCGCGGCCGACTTGCCTCTACTTC-3Ј (for P2 targeting vector, 3Ј arm, 3.0 kb). (The restriction sites used for cloning are underlined). The identities of the constructs were verified by DNA sequencing.
Antibodies-The Dnmt3a and Dnmt3b rabbit polyclonal antibodies, 164 and 157, were generated against mouse Dnmt3a amino acids 15-126 and Dnmt3b amino acids 1-181, respectively. The Dnmt3a monoclonal antibody (mAb) (clone 64B1446) was purchased from Imgenex. Anti-GFP mAb (a mixture of clones 7.1 and 13.1) was obtained from Roche. Anti-tubulin mAb (Ab-1) was obtained from Oncogene Research Products. Anti-DNMT1 (human) polyclonal antibody was purchased from New England Biolabs. Anti-histone H1 (AE-4) and anti-lamin B (M-20) were obtained from Santa Cruz Biotechnology.
Protein Expression and Analysis-Transient transfection was carried out in COS-7, NIH 3T3, or ES cells using LipofectAMINE PLUS reagent (Invitrogen). Cell fractionation, immunoprecipitation, immunoblotting, and fluorescence microscopy analyses were performed as previously described (26 -28) .
Luciferase Reporter Assay-Luciferase reporter constructs as well as pGL-3-Basic (empty vector) were individually co-transfected with pRL-TK (internal control, Promega) into ES cells or NIH 3T3 cells. The cell lysates were analyzed for luciferase activities using the dual-luciferase reporter assay system (Promega).
5Ј-Rapid Amplification of cDNA Ends (RACE), Reverse Transcription (RT)-PCR, and
Northern Hybridization-5Ј-RACE was carried out on total RNA prepared from ES cells using the 5Ј-RACE system (Invitrogen) with Dnmt3a-specific primers: 5Ј-AGCTGCTCGGCTCCGGCC-3Ј (for reverse transcription), 5Ј-TCCCCCACACCAGCTCTCC-3Ј (for first round of PCR), and 5Ј-CTGCAATTACCTTGGCTT-3Ј (for second round of PCR). For RT-PCR analysis, total RNA was reverse-transcribed with oligo(dT) [12] [13] [14] [15] [16] [17] [18] , and the resulting cDNAs were amplified by PCR. The PCR products were analyzed either by ethidium bromide staining (for Dnmt3a) or Southern hybridization using cDNA fragments as probes (for Dnmt3b). Dnmt3a-specific primers used are 5Ј-TCCAGCGGCCCC-GGGGAC-3Ј (F1), 5Ј-CCCAACCTGAGGAAGGGA-3Ј (F2), 5Ј-ACCAAC-ATCGAATCCATG-3Ј (F3), 5Ј-TCCCGGGGCCGACTGCGA-3Ј (F4), 5Ј-AGGGGCTGCACCTGGCCTT-3Ј (F5), 5Ј-TCCCCCACACCAGCTCTC-C-3Ј (R1), and 5Ј-CCTCTGCAGTACAGCTCA-3Ј (R2). Dnmt3b-specific primers used are 5Ј-TGGGATCGAGGGCCTCAAAC-3Ј and 5Ј-TTCCA-CAGGACAAACAGCGG-3Ј (for exon 10) and 5Ј-GCGACAACCGTCCA-TTCTTC-3Ј and 5Ј-CTCTGGGCACTGGCTCTGACC-3Ј (for exons 21 and 22) . Northern hybridization was performed according to standard protocols. Dnmt3a cDNA fragments used as probes were generated by PCR. The primer pairs used were 5Ј-GCAGAGCCGCCTGAAGCC-3Ј and 5Ј-CCTTTTCCAACGTGCCAG-3Ј (for probe 1) and 5Ј-GCCAAGG-TAATTGCAGTA-3Ј and 5Ј-GATGTTTCTGCACTTCTG-3Ј (for probe 2).
Targeted Disruption of Dnmt3a2 in ES Cells-The P2 targeting vector was electroporated into Dnmt3a ϩ/Ϫ ES cells (7), which were subsequently selected in hygromycin-containing medium. Genomic DNA isolated from hygromycin-resistant colonies was digested with ScaI and analyzed by Southern hybridization using a 0.45-kb KpnISpeI fragment as a probe.
DNA Methyltransferase Assays-For in vitro DNA methyltransferase activity, His 6 -tagged Dnmt3a proteins were incubated with doublestranded poly(dI-dC) (Pharmacia) in the presence of S-adenosyl-L-methionine (methyl-3 H) (SAM, PerkinElmer Life Sciences), and the incorporation of 3 H methyl groups into poly(dI-dC) was measured as previously described (4, 21) . The reactions were carried out at 37°C for 1 h in methylation buffer (20 mM Tris-HCl, pH 7.4, 40 mM NaCl, 5 mM EDTA, 200 g/ml bovine serum albumin, 25% glycerol, and 1 mM dithiothreitol) containing the purified enzyme, the substrate DNA, and SAM at concentrations of 0.5 M, 2 M, and 2 M, respectively. For de novo methylation activity, human EC cell lines and breast/ovarian cancer cell lines were infected with Moloney murine leukemia virus, and the methylation status of newly integrated provirus was analyzed as previously described (8) .
RESULTS
Identification of Dnmt3b6 and Dnmt3a2-The Dnmt3a and Dnmt3b proteins show high sequence homology in the C-terminal catalytic domain, but they share little sequence similarity in the N-terminal regulatory region except for the conserved proline-tryptophan-tryptophan-proline and plant homeodomain domains (Fig. 1A) . To characterize the Dnmt3a and Dnmt3b proteins, we generated rabbit polyclonal antibodies against the N-terminal regions of mouse Dnmt3a (antibody 164) and Dnmt3b (antibody 157) and also obtained a commercial mAb (64B1446), which was raised against the full-length mouse Dnmt3a. The epitope recognized by 64B1446 was mapped to a region (amino acids 705-908) at the C terminus (data not shown). The specificity of these antibodies was examined using GFP fusion proteins expressed in Cos-7 cells (Fig.  1B) . Anti-GFP immunoblotting showed the expression of the GFP fusion proteins (first panel). The polyclonal antibodies, 164 and 157, were specific for Dnmt3a and Dnmt3b, respectively (second and third panels). The mAb, 64B1446, reacted strongly with Dnmt3a proteins and weakly with Dnmt3b1 and Dnmt3b2, but not Dnmt3b3 (fourth panel), consistent with the epitope-mapping results.
Previous studies showed that Dnmt3a and Dnmt3b transcripts were abundant in ES cells (4), but their protein products were not analyzed. To address this question, we analyzed wildtype (J1), Dnmt3a Ϫ/Ϫ (6aa), Dnmt3b Ϫ/Ϫ (8bb), and [Dnmt3a Ϫ/Ϫ , Dnmt3b Ϫ/Ϫ ] (7aabb) mutant ES cells (7) by immunoblotting with the Dnmt3a and Dnmt3b antibodies (Fig. 1, C and D) . Two distinct bands, which migrated at ϳ120 and ϳ110 kDa, were detected by antibody 157 in J1 and 6aa cells, but not in 8bb and 7aabb cells (Fig. 1C) , indicating that these bands represent Dnmt3b proteins. The more abundant 120-kDa band most likely represents Dnmt3b1, and the 110-kDa band represents an isoform smaller than Dnmt3b2 but slightly larger than Dnmt3b3 (Fig. 1C) . RT-PCR analysis confirmed the expression of two major Dnmt3b transcripts in ES cells; one corresponds to Dnmt3b1 and the other is an alternatively spliced variant that lacks exons 21 and 22 ( Fig. 6 and data not shown). We named this new isoform Dnmt3b6 (schematically shown in Fig. 1A) . Indeed, the 110-kDa band observed in ES cells co-migrated with protein expressed from Dnmt3b6 cDNA (Fig. 1C, lanes 8 and 9). Dnmt3b6 lacks motif IX and thus may not be enzymatically active, like Dnmt3b3 (21).
Dnmt3a-specific antibody 164 detected a single band of ϳ130 kDa in J1 and 8bb cells, which co-migrated with the control Dnmt3a protein (Fig. 1D , lanes 1, 2, and 5), but not in 6aa and 7aabb cells (lanes 3 and 4) . Surprisingly, when the same blot was reprobed with anti-Dnmt3a mAb 64B1446, two more intense bands of ϳ120 kDa and ϳ100 kDa were detected in addition to the 130-kDa Dnmt3a protein in J1 cells (Fig. 1D,  lane 7) . The 120-kDa band represents Dnmt3b1, as it was also present in 6aa cells but absent in 8bb cells (lanes 9 and 10). Like the 130-kDa Dnmt3a protein, the 100-kDa band could be detected in 8bb cells (lane 10) but not in 6aa and 7aabb cells (lanes 8 and 9), indicating that it is a novel product of the Dnmt3a gene. We named this short form Dnmt3a2. Importantly, the immunoblotting result indicates that Dnmt3a2 is the predominant Dnmt3a gene product in ES cells (Fig. 1D) .
The fact that Dnmt3a2 could not be recognized by antibody 164 suggests that Dnmt3a2 lacks the N-terminal region of Dnmt3a. Inspection of the Dnmt3a cDNA sequence revealed that, in addition to the known initiation codon (ATG1), two downstream in-frame ATGs (ATG2 and ATG3), corresponding to Met-159 and Met-220, were found to be within the Kozak consensus sequence. To test the possibility that Dnmt3a2 was produced by translation initiated at one of these ATGs, we expressed in 6aa cells two Dnmt3a proteins with the N-terminal 158 and 219 amino acids truncated and showed that Dnmt3a (220 -908) co-migrated with endogenous Dnmt3a2 from J1 cells (Fig. 1E, compare lanes 3 and 4) . This result suggests that ATG3 might be the initiation codon for Dnmt3a2. To further determine whether Dnmt3a2 is produced from the same mRNA transcript as Dnmt3a, we transfected 6aa cells with an expression vector containing the entire Dnmt3a coding sequence. Immunoblotting analysis using antibody 64B1446 showed that only Dnmt3a was expressed (Fig. 1F, lane 2) . These results suggest that Dnmt3a2 does not derive from Dnmt3a transcript by the use of an alternative ATG or from Dnmt3a protein by proteolytic cleavage or degradation.
Dnmt3a2 Is Encoded by Transcripts Initiated from a Down- Ϫ/Ϫ (6aa), Dnmt3b Ϫ/Ϫ (8bb), and (Dnmt3a Ϫ/Ϫ , Dnmt3b Ϫ/Ϫ ) double-mutant (7aabb) ES cells as well as Cos-7 cells transfected with different Dnmt3b isoforms were immunoblotted with Dnmt3b-specific antibody 157. D, ES cells express at least two forms of Dnmt3a proteins, Dnmt3a and Dnmt3a2. The same ES cell lysates as described in C, as well as control Dnmt3a protein expressed in Cos-7 cells were immunoblotted with Dnmt3a-specific antibody 164 (lanes 1-5) and the mAb 64B1446 (lanes 6 -10). E, Dnmt3a2 co-migrates with a truncated Dnmt3a protein lacking the N-terminal 219 amino acid residues. Plasmid constructs encoding N-terminally truncated Dnmt3a proteins or vector alone were transfected into 6aa ES cells. The overexpressed proteins as well as endogenous Dnmt3a2 (from J1 cells) were immunoprecipitated and detected with antibody 64B1446. Note that lysis buffer containing low salt (150 mM NaCl) could not extract Dnmt3a and Dnmt3b1. F, Dnmt3a2 cannot be derived from Dnmt3a cDNA. Plasmid construct encoding Dnmt3a or vector alone was transfected into 6aa ES cells. The transfected cells as well as J1 cells were lysed and immunoblotted with antibody 64B1446.
stream Promoter-To determine whether Dnmt3a and Dnmt3a2 are encoded by distinct mRNA transcripts, total RNA from J1, 6aa ES cells, and NIH 3T3 cells (which express only Dnmt3a; see Fig. 7 ) was analyzed by Northern hybridization with Dnmt3a cDNA probes upstream or downstream of ATG3 (Fig. 2B) . The downstream probe ( Fig. 2A , Probe 2) detected two major transcripts of 4.2 kb and 4.0 kb and a weak band of 9.5 kb from J1 cells (Fig. 2B, lane 5) , consistent with our previous results (4) . All of the transcripts were smaller, and the intensity of 4.2 kb and 4.0 kb bands was substantially reduced in 6aa cells (lane 6), indicating that truncated transcripts were generated. The 9.5-kb transcript was also present at low level in NIH 3T3 cells, but the 4.2-kb and 4.0-kb transcripts were absent (lane 4). Interestingly, the upstream probe ( Fig. 2A , Probe 1) recognized the 9.5-kb transcript in NIH 3T3 and J1 cells and a 7.5-kb truncated form in 6aa cells, but it failed to hybridize to the 4.2-kb and 4.0-kb transcripts in J1 cells (lanes  1-3) . Taken together, these observations suggest that Dnmt3a2 is probably encoded by the 4.2-kb and 4.0-kb transcripts. Our previous data indicated that the 4.2-kb and 4.0-kb transcripts differ in their 3Ј-untranslated region, probably due to alternative 3Ј processing (4) . It remains to be determined whether Dnmt3a is encoded by the 9.5-kb transcript or whether the Dnmt3a signal is too weak to be detected.
To determine the identity of the Dnmt3a transcripts, we performed 5Ј-RACE on RNA prepared from J1 ES cells with primers annealing to Dnmt3a sequences downstream of the putative Dnmt3a2 translation start site (ATG3 at M220). Two species of Dnmt3a transcripts were obtained. One of them matched the Dnmt3a cDNA sequence, and the other contained a 55-bp sequence at its 5Ј end that did not match any known Dnmt3a cDNA sequence. Searches of the Celera mouse-genome data base revealed that the 55-bp sequence was part of an exon located in an intron of the Dnmt3a gene. Using the new exon sequence as query, we identified a mouse expressed sequence tag clone, BE855330, which extended the exon to at least 117 bp. Sequencing analysis revealed that the expressed sequence tag clone shared all the downstream exons with Dnmt3a ( Fig.  2A) . We conclude that the newly identified transcript encodes Dnmt3a2, because its open reading frame would predict a protein that lacks the N-terminal 219 amino acids of Dnmt3a ( Fig. 2A) . As illustrated in Fig. 2A , the murine Dnmt3a gene consists of 24 exons. Exons 8 -24 are shared by both Dnmt3a and Dnmt3a2. Exons 1-6 are present only in Dnmt3a, whereas exon 7 (indicated by an asterisk) is unique to Dnmt3a2. By RT-PCR analysis and data base searches, we also identified human DNMT3A2 (Fig. 2A) . It is very similar to its murine homologue except that it contains an additional sequence of 68 bp in the 5Ј-untranslated region, which is encoded by an extra exon located ϳ2.5 kb downstream of exon 7 (the newly identified exons are indicated by an asterisk). The predicted mouse Dnmt3a2 and human DNMT3A2 proteins, each consisting of 689 amino acids ( Fig. 2A) , show high sequence identity (98.5%).
The 5Ј-RACE results were confirmed by RT-PCR analysis of total RNA from J1 cells using primers annealing to different Dnmt3a exons (Fig. 2A) . Combination of Dnmt3a-specific (F1-F4) or Dnmt3a2-specific (F5) primers with a downstream primer in exon 9 (R1) verified the expression of both Dnmt3a and Dnmt3a2 transcripts in ES cells (Fig. 2C, lanes 1-4 and  9 -16 ). However, combination of the same Dnmt3a primers (F1-F4) with a primer in the unique Dnmt3a2 exon (R2) failed to generate any PCR products (lanes 5-8) . These results indicate that it is unlikely that the Dnmt3a and Dnmt3a2 transcripts are produced via alternative splicing.
The observation that the Dnmt3a2-specific exon is located in a region Ͼ80 kb downstream of the putative Dnmt3a promoter suggests that Dnmt3a2 transcription may be driven by a different promoter. Indeed, analysis of the large (ϳ18 kb) "intron" preceding exon 7 with PROSCAN (bimas.dcrt.nih.gov/molbio/ proscan) predicted that a 1.4-kb region immediately upstream of exon 7 has a high probability to function as a promoter. It should also be noted that the unique Dnmt3a2 exon resides in a GC-rich CpG island, which is a hallmark of the promoter region of genes. We tested the transcriptional activity of the (lanes 1-3) or Probe 2 (lanes 4 -6) . As a loading control, the 28S rRNA stained with ethidium bromide was shown at the bottom. C, total RNA from J1 cells was reverse transcribed using poly (dT) [12] [13] [14] [15] [16] [17] [18] , and the resulting cDNAs were subjected to PCR amplification with the indicated Dnmt3a primers. Dnmt3a cDNA was used as a positive control.
putative promoter using a reporter system (Fig. 3) . A ϳ2.0-kb genomic fragment that includes the putative promoter (P2) was inserted, in both orientations, upstream of the cDNA encoding the firefly luciferase followed by the SV40 late poly(A) signal (Fig. 3A) . Transient-transfection experiments demonstrated that the P2 fragment has high promoter activity in ES cells but much lower activity in NIH 3T3 cells (Fig. 3B, P2-luc) , consistent with the expression levels of Dnmt3a2 in these cell types (Fig. 2B) . The transcriptional activity of the P2 fragment is orientation-dependent, as the same fragment showed no promoter activity when subcloned in reverse orientation (Fig. 2B,  P2R-luc) . As a positive control, SV40 promoter worked equally well in both cell types (data not shown). These data strongly suggest that the region 5Ј adjacent to exon 7 functions as a promoter and drives the expression of Dnmt3a2.
To confirm that exon 7 and the adjacent promoter are essential for the expression of Dnmt3a2, we deleted the P2 region from the wild-type allele in Dnmt3a ϩ/Ϫ ES cells (7) by gene targeting. An hCMV-hygTK cassette was inserted in the opposite orientation of Dnmt3a transcription to avoid disruption of the Dnmt3a transcripts (Fig. 4A) . We therefore expected that the removal of these sequences would abolish the transcription of Dnmt3a2 but not Dnmt3a. One clone (296) with deletion of the wild-type allele was successfully isolated (Fig. 4B) . As expected, Northern hybridization showed that the 4.2-kb and 4.0-kb transcripts were completely abolished in clone 296 cells (Fig. 4C) . Consistently, immunoprecipitation and immunoblotting analyses demonstrated that Dnmt3a2 protein was abolished, whereas Dnmt3a protein was produced in clone 296 cells at similar levels as in Dnmt3a ϩ/Ϫ cells (Fig. 4D ). These data provide genetic evidence that the newly identified Dnmt3a2 is indeed encoded by mRNA transcribed from a downstream promoter.
Dnmt3a2 and Dnmt3a Show Similar Methyltransferase Activity but Different Subcellular Localization Patterns-To test
whether Dnmt3a2 has methyltransferase activity, we generated recombinant Dnmt3a proteins and measured their catalytic activity by a standard in vitro methylation assay. Dnmt3a, Dnmt3a:PC3 VD, and Dnmt3a2 were expressed in Escherichia coli as N-terminally His 6 -tagged fusion proteins and purified by metal chelation chromatography. The proteins were ϳ90% pure, as estimated by Coomassie blue staining (Fig. 5A, lanes  1-3) , and their identity was verified by immunoblotting (lanes 4 -6). As shown previously (4), Dnmt3a was able to transfer methyl groups to double-stranded poly(dI-dC). Mutation of the PC motif in the catalytic domain (Dnmt3a:PC3 VD) abolished the activity. Dnmt3a2 showed similar enzyme activity as Dnmt3a (Fig. 5B) , demonstrating that Dnmt3a2 is an active DNA methyltransferase.
FIG. 3.
A region 5-adjacent to the Dnmt3a2 unique exon has promoter activity. A, schematic representation of the luciferase reporter constructs. The genomic region that contains the Dnmt3a2 unique exon (exon 7, black bar) embedded in a GC-rich region (striped bar) is shown at the top. The putative Dnmt3a2 transcription start site is indicated. In the reporter constructs, a 2.0-kb genomic fragment that contains part of exon 7 and the putative promoter region was inserted in both orientations upstream of the cDNA encoding the firefly luciferase (luc) followed by the SV40 late poly(A) signal (pA). B, luciferase activity assay. ES cells and NIH 3T3 cells were transfected with the reporter constructs (P2-luc and P2R-luc) and the empty vector pGL-3-Basic (luc) in the presence of pRL-TK (expresses Renilla luciferase), and luciferase activities were measured by luminescence. Firefly luciferase activity was normalized to Renilla luciferase activity to minimize transfection-efficiency variations. The results were expressed as relative activity using the background activity generated by the empty vector as baseline. Each bar represents the mean ϩ S.D. of data from six independent reactions performed in two separate experiments. It has been reported that Dnmt3a localizes to heterochromatin (22) . To determine whether Dnmt3a2 localizes differently from Dnmt3a, we expressed GFP-Dnmt3a fusion proteins in NIH 3T3 cells, and their localization was analyzed by fluorescence microscopy. Dnmt3a localized exclusively in the nuclei and concentrated in nuclear foci that correspond to DAPI (4Ј,6-diamidino-2-phenylindole) bright spots, consistent with heterochromatin association. In contrast, Dnmt3a2 showed a diffused pattern excluding nucleoli and heterochromatin. Although Dnmt3a2 localized mainly in the nuclei, weak staining was also observed in the cytoplasm (Fig. 5C) . Similar results were obtained when the GFP fusion proteins were expressed in ES cells (data not shown). These data indicate that the N-terminal 219 amino acids of Dnmt3a are required for its exclusive nuclear localization and heterochromatin association.
To confirm the localization data, we investigated the subcellular distribution of endogenous Dnmt3a proteins. ES cells were extracted sequentially to obtain the cytoplasmic, chromatin, and nuclear matrix fractions. Immunoblotting analysis with antibody 64B1446 showed that Dnmt3a and Dnmt3a2 as well as Dnmt3b1 fractionate mainly with chromatin (77-85%), and small proportions (8 -18%) of these proteins also associate with the nuclear matrix (Fig. 5D) . Whereas Dnmt3a and Dnmt3b1 were exclusively nuclear, a significant proportion (15%) of Dnmt3a2 was present in the cytoplasmic fraction (Fig.  5D) , consistent with the localization results (Fig. 5C ). The efficacy of the fractionation procedure was verified by immunoblotting with control antibodies specific to histone H1 (a component of chromatin) and lamin B (a nuclear matrix-associated protein) (Fig. 5D ). Taken together, our results suggest that Dnmt3a associates mainly with heterochromatin and Dnmt3a2 associates primarily with euchromatin.
Expression of Dnmt3a2 and Dnmt3b in Mouse Tissues and Human Cell Lines Correlate with de Novo Methylation
Activity-Because de novo methylation activity changes during differentiation, we examined the levels of Dnmt3a and Dnmt3b proteins in differentiating ES cells. ES cells were differentiated as embryoid bodies in vitro for 14 days, and the change of Dnmt3a and Dnmt3b protein levels was monitored by immunoblotting (Fig. 6A) . Dnmt3a, Dnmt3a2, and Dnmt3b were all up-regulated upon differentiation, with the highest level observed in embryoid bodies at 4 -6 days. However, after 6 days of differentiation, the level of Dnmt3a2 and Dnmt3b rapidly decreased, whereas the level of Dnmt3a sustained throughout the course of the experiment.
We then examined the expression of Dnmt3a and Dnmt3b proteins in somatic tissues from 3-week-old mice by immunoprecipitation and immunoblot analysis. As shown in Fig. 6B , Dnmt3a was detected in all tissues except for small intestines, whereas Dnmt3a2 and Dnmt3b expression was more restricted. Both Dnmt3a2 and Dnmt3b proteins were detected in testis, spleen, and thymus, tissues known to contain cells that undergo active de novo methylation. Dnmt3b was also present at low level in liver (Fig. 6B) . RT-PCR analysis confirmed the immunoblotting results and also revealed the expression of Dnmt3a2 and Dnmt3b in ovary (Fig. 6, C and D) . Based on the presence or absence of Dnmt3b exon 10 and/or exons 21/22, we were able to determine the Dnmt3b isoforms (Fig. 6D) . Therefore, the Dnmt3b doublets observed in testis, spleen, thymus, and liver (Fig. 6B ) most likely represent Dnmt3b2 and Dnmt3b3. Of note is that the relative levels of Dnmt3b2 and Dnmt3b3 are different in these tissues (Fig. 6B) . Although Dnmt3b proteins could not be detected in many tissues (Fig.  6B) , low levels of Dnmt3b transcripts (mainly Dnmt3b3) were expressed ubiquitously (Fig 6D) . Dnmt3b1 and Dnmt3b6 were detected only in ES cells (Fig. 6D ). These observations, along FIG. 5. Dnmt3a and Dnmt3a2 have similar methyltransferase activity but exhibit different subcellular localization patterns. A, production of recombinant Dnmt3a proteins. His 6 -tagged Dnmt3a, Dnmt3a:PC3 AD, and Dnmt3a2 were expressed in E. coli and purified by metal chelation chromatography. The purity of the recombinant proteins was estimated by Coomassie blue staining (lanes 1-3) and their identity was verified by immunoblotting with antibody 64B1446 (lanes 4 -6) . B, methylation of double-stranded poly(dI-dC) by Dnmt3a and Dnmt3a2. The methyltransferase activity of the recombinant proteins was measured in vitro as described under "Experimental Procedures." The results were expressed as the amount (mole) of methylated product generated per mole of enzyme. Each bar represents the mean ϩ S.D. of data from three independent reactions. C, localization of Dnmt3a and Dnmt3a2. GFP-Dnmt3a and Dnmt3a2 were transfected in NIH3T3 cells, and the cells were fixed and analyzed by fluorescence microscopy. The upper panel shows the GFP signal, and the lower panel shows the nuclei stained with 4Ј,6-diamidino-2-phenylindole (DAPI). The arrows point to two heterochromatin regions and are used for orientation. D, subcellular distribution of endogenous Dnmt3a and Dnmt3b proteins. ES cells were extracted to obtain the cytoplasmic, chromatin, and the nuclearmatrix fractions (left). Equal amounts of each fraction were analyzed by immunoblotting with antibody 64B1446 (right, first panel), antihistone H1 (second panel), and anti-lamin B (third panel) . The relative amount (percentage) of total protein in each fraction was estimated for each protein by measuring the intensities of the bands with the software NIH Image 1.62 (fourth panel).
with the dynamic changes during ES cell differentiation, indicate that Dnmt3a2 and Dnmt3b are coordinately regulated and their expression correlates with de novo methylation activity.
Because overexpression of DNMT1, DNMT3A, and DNMT3B transcripts have been reported in various human cancers, we examined the expression of various DNMT proteins in EC and breast/ovarian cancer cell lines by immunoblotting. Five EC cell lines expressed relatively high levels of DNMT3A2 and low levels of DNMT3A (Fig. 7A) . DNMT3B was also highly expressed in these cells, but different cells expressed different isoforms (Fig. 7B) . In several breast and ovarian cancer cell lines, DNMT1 was expressed at comparable levels, which was similar to the level in an EC cell line, NCCIT (Fig. 7C , first panel) (note that the antibody does not recognize mouse Dnmt1 in J1 and NIH 3T3 cells). Low levels of DNMT3A were detected in most cell lines (Fig. 7C, second panel) . Although DNMT3A2 and DNMT3B proteins were also detectable in most of the breast/ovarian cancer cell lines, their levels were very low compared with EC and ES cells (Fig. 7C, third and fourth  panels) .
We then investigated whether the expression levels of DNMT proteins correlate with de novo methylation activity. Human EC cell lines and breast and ovarian cancer cell lines were infected with Moloney murine leukemia virus (MMLV, Fig. 7D, lower) , and the methylation status of proviral DNA was analyzed using the CpG methylation-sensitive enzyme HpaII (Fig. 7D) . The proviral DNA was partially or completely methylated in the EC cell lines, as indicated by the presence of HpaII-resistant bands ranging from 0.8 kb (unmethylated band) to 1.3 kb (fully methylated band), and the level of methylation increased with time (lanes 4 -13, compare day 5 and day 20). In contrast, little or no de novo methylation activity was detected in any of the breast and ovarian cancer cell lines examined (lanes 14 -21) . Because DNMT1 was readily detected in all of the cell lines (Fig. 7C) , our results provide additional evidence that DNMT1 does not have de novo methyltransferase activity to the provirus DNA, consistent with the current view that it functions as a maintenance enzyme. It is also unlikely that DNMT3A caused the difference in de novo methylation between EC cell lines and breast/ovarian cancer cells, because the expression level of DNMT3A is low but similar in both groups of cell lines (Fig. 7C) . The absence of DNMT3B1/3B2 in several EC cell lines (PA-1, NTERA-2, and Tera-2) suggested that the de novo methylation activity observed in these cells could be attributed to the activity of DNMT3A2. Our results are therefore most consistent with the notion that DNMT3A2 and DNMT3B1/3B2 are responsible for active de novo methylation of provirus DNA in ES and EC cells.
DISCUSSION
In this study we demonstrate that the Dnmt3a gene encodes at least two isoforms, termed Dnmt3a and Dnmt3a2, of ϳ130 kDa and 100 kDa, respectively. The newly identified Dnmt3a2 protein, which lacks the N-terminal region of Dnmt3a, is encoded by transcripts initiated from a downstream promoter and represents the major isoform in ES cells and EC cells. Our conclusion is supported by several lines of evidence from molecular and genetic analyses of wild-type and Dnmt3a-deficient ES cells. First, antibodies specific to the N-terminal region of Dnmt3a failed to detect the 100-kDa protein in ES cells and a 5Ј-cDNA probe upstream of the first coding exon of Dnmt3a2 failed to hybridize to the major 4.0-kb and 4.2-kb transcripts. Second, 5Ј-RACE and RT-PCR analysis identified a 5Ј-exon upstream of the Dnmt3a2 coding region, which is located in a large intron of Dnmt3a. Third, a GC-rich "intronic" region upstream of the Dnmt3a2-specific exon showed strong promoter activity for the expression of a reporter gene in ES cells and much lower activity in NIH 3T3 cells, consistent with Dnmt3a2 expression status in these cells. Finally, deletion of the putative promoter region abolished Dnmt3a2 transcripts and Dnmt3a2 protein, whereas transcription and translation of Dnmt3a were unaffected.
Although both Dnmt3a and Dnmt3a2 are active DNA methyltransferases as shown by in vitro assays, they differ from one another in two main features. First, Dnmt3a2 showed a diffused nuclear staining pattern excluding heterochromatin, in contrast to Dnmt3a, which is concentrated in heterochromatin. An intriguing possibility is that Dnmt3a and Dnmt3a2 may modify different chromatin domains, with Dnmt3a preferentially methylating heterochromatin and Dnmt3a2 preferentially methylating euchromatin. Given that hypermethylation of single-copy genes, which usually reside in euchromatic re- Ϫ/Ϫ mice (3 weeks old) were homogenized and lysed, and the lysates were immunoprecipitated and immunoblotted with Dnmt3a (64B1446) antibody (upper panel) or Dnmt3b antibody 157 (lower panel). ES cells were used as a positive control. Note that 64B1446 cross-reacts with a nonspecific band of ϳ105 kDa (indicated by an asterisk) in some tissues. Br, brain; Li, liver; Mu, muscle; Te, testis; Ht, heart; Sp, spleen; Th, thymus; St, stomach; Si, small intestine. C, total RNA isolated from different tissues was analyzed by RT-PCR using primers specific to Dnmt3a (upper panel) or Dnmt3a2 (lower panel). Lu, lung; Ov, ovary. D, the same RNA samples were analyzed by RT-PCR using Dnmt3b-specific primers flanking exon 10 (upper panel) or exons 21-22 (lower panel) followed by Southern hybridization using Dnmt3b cDNA fragments as probes. Dnmt3b1 and Dnmt3b3 cDNAs were used as controls (lanes 1 and 2) . The bands representing the presence (ϩ) or absence (Ϫ) of exon 10 or exons 21-22 are indicated on the right, and the major Dnmt3b isoforms present in ES cells and each tissue are indicated at the bottom.
gions, contributes to diseases such as cancers, the association of Dnmt3a2 with euchromatin is exciting. Notably, Dnmt3a2 is detectable in many breast/ovarian cancer cell lines, although the expression level is not sufficient to cause rapid de novo methylation of provirus (Fig. 7) . It would be interesting to determine whether Dnmt3a2 plays a role in certain stages of tumorigenesis. Second, expression of Dnmt3a2 is developmentally regulated, whereas Dnmt3a is ubiquitously expressed. We observed that Dnmt3a2 is expressed only in tissues, such as testis, ovary, spleen, and thymus, in which de novo methylation is believed to occur during cellular differentiation. Analysis of de novo methylation activity in human cell lines also suggested that DNMT3A2 is capable of methylating newly integrated retroviral DNA. Therefore, Dnmt3a2 may function as a de novo methyltransferase. The absence of Dnmt3a2 in most somatic tissues suggests that expression of Dnmt3a2 must be tightly regulated to avoid abnormal de novo methylation, which could be toxic to cells. Consistent with this hypothesis, we found that it was difficult to establish stable cell lines with overexpression of Dnmt3a2, but not when Dnmt3a or mutated Dnmt3a2 (mutation of the PC motif) was overexpressed (data not shown).
In this study, we also identified a novel isoform of Dnmt3b, termed Dnmt3b6. We showed that different Dnmt3b isoforms exhibit different tissue distribution. Dnmt3b1 and Dnmt3b6 are the predominant forms in ES cells, whereas Dnmt3b2 and Dnmt3b3 are expressed at relatively high levels in testis, ovary, spleen, thymus, and liver. Although Dnmt3b1 and Dnmt3b2 have been shown to possess enzyme activity (4, 21) , the function of Dnmt3b3 and Dnmt3b6 remains elusive. We speculate that Dnmt3b1 and Dnmt3b2 function as de novo methyltransferases, whereas Dnmt3b3 (and probably Dnmt3b6), which by itself seems to have no enzymatic activity, may function as a regulator of DNA methylation.
Genetic studies have shown that Dnmt3a and Dnmt3b are essential for de novo methylation in ES cells and during embryonic development (7) . Because Dnmt3a and Dnmt3b isoforms show different biochemical properties and expression patterns, they may have distinct functions in development. Dnmt3a2 and Dnmt3b1 are the major isoforms detected in ES cells and likely have redundant function in carrying out de novo methylation of provirus DNA (7). Interestingly, the expression level of both Dnmt3a and Dnmt3a2, and different Dnmt3b isoforms is elevated during early stages of ES cell differentiation, but only Dnmt3a expression persists to the late differentiation stage, reminiscent of Dnmt3a and Dnmt3b expression in embryos (7) . We speculate that Dnmt3a2 and Dnmt3b1/3b2 may be involved in de novo methylation in early postimplantation embryos. While these enzymes may have overlapping functions in modifying various genomic sequences, protein targeting may confer specificity to them as well. Lack of access to heterochromatin may explain why Dnmt3a2 cannot compensate for Dnmt3b in methylating centromeric minor satellite repeats (7). Dnmt3a2 and Dnmt3b are also expressed at relatively high levels in testis, ovary, spleen, and thymus and may play an important role in regulation of genomic imprinting, gametogenesis, and lymphocyte differentiation. We have recently shown that disruption of both Dnmt3a and Dnmt3a2 by deleting the conserved motifs in the catalytic domain perturbs de novo methylation of maternally imprinted genes during oocyte maturation and spermatogenesis (13) .
2 Dnmt3a (and Dnmt3b3) is expressed at low levels in most tissues and cell lines analyzed, suggestive of a housekeeping function. Genetic analysis by isoform-specific gene ablation will be necessary to elucidate the specific function of each of the Dnmt3a and Dnmt3b isoforms.
Acknowledgements-We thank Z. Wang for technical assistance and members of our laboratory for discussion. 1, 11, and 12 ). An equal amount of proteins (30 g per lane) from the indicated cell lysates was analyzed by immunoblotting with the indicated antibodies. Note that the anti-DNMT1 antibody does not recognize mouse Dnmt1. D, de novo methylation activity in human cell lines. The indicated cells were infected with Moloney Murine Leukemia Virus (MMLV). At 5 (D5) or 20 (D20) days after infection, genomic DNA was digested with KpnI alone (K), KpnI plus the CpG methylation-insensitive enzyme MspI (K/M), or KpnI plus the CpG methylation-sensitive enzyme HpaII (K/H) and analyzed by Southern hybridization using the pMu3 probe. As schematically illustrated at the bottom, the pMu3 probe would hybridize with a 1.3-kb KpnI fragment of MMLV, and five HpaII/MspI sites (vertical lines with rods) are present in this region. In this assay, the methylation status of these sites was determined with KpnI-HpaII digestion: complete methylation resulted in a 1.3-kb band; no methylation resulted in a 0.8-kb band and a few smaller bands (too small to be shown); and partial methylation resulted in different bands ranging from 0.8 -1.3 kb. DNA from uninfected (D0) PA-1 cells was used as a negative control (lane 1).
